Range of generics will be withdrawn across Europe

BMJ 2016; 354 doi: (Published 26 July 2016) Cite this as: BMJ 2016;354:i4141
  1. Nigel Hawkes
  1. London

Many generic medicines sold across Europe will have to be withdrawn from the market, after the European Medicines Agency (EMA) said that studies carried out in India cannot be relied on.1

The ban covers generic medicines approved after studies at Semler Research Centre, Bengaluru (Bangalore), certified that they were biologically equivalent to the original drugs. The EMA is following the lead of the US Food and Drug Administration and the World Health Organization, which inspected Semler’s laboratories at the end …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to to receive unlimited access to all content on for 14 days.
Sign up for a free trial